Curium to buy Lantheus in up to $8 billion deal
LNTH•Curium agrees to acquire Lantheus
Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.
LNTH•LNTH•LNTH•Curium has agreed to buy radiopharmaceutical company Lantheus Holdings in a deal worth up to $8 billion, the companies said on Monday.
